F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Simeprevir

Page 1 of 1 ( 11 items )
<<
1
>>

1	Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C 2/17/2017 8:32:00 AM \| Browse: 1192 \| Download: 2217
2	Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12 9/14/2016 7:04:00 PM \| Browse: 1598 \| Download: 3238
3	Chronic hepatitis C: This and the new era of treatment 1/15/2016 9:49:00 AM \| Browse: 2043 \| Download: 2117
4	Comparison of peg-interferon, ribavirin plus telaprevir vs simeprevir by propensity score matching 12/4/2015 3:24:00 PM \| Browse: 1511 \| Download: 3293
5	Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents 12/2/2015 12:01:00 PM \| Browse: 1331 \| Download: 1931
6	Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs 11/24/2015 3:55:00 PM \| Browse: 1597 \| Download: 3021
7	All-oral interferon-free treatments: The end of hepatitis C virus story, the dream and the reality 10/2/2015 7:07:00 PM \| Browse: 1435 \| Download: 2387
8	Hepatitis C cirrhosis: New perspectives for diagnosis and treatment 7/24/2015 7:52:00 PM \| Browse: 1549 \| Download: 2390
9	Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand? 6/29/2015 5:40:00 PM \| Browse: 1628 \| Download: 2568
10	Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 6/29/2015 4:40:00 PM \| Browse: 1562 \| Download: 3007
11	Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis: First case report 1/20/2015 9:10:00 PM \| Browse: 1369 \| Download: 2108

Page 1 of 1 ( 11 items )
<<
1
>>

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.